COPENHAGEN, Denmark, Sept. 29, 2026 -- Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, today announced the successful close of...
Barry Myers is a featured speaker at CED's MedTech 2008 Conference in Durham, NC
News | 03. 08. 2008
